|
Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy
RECRUITINGN/ASponsored by Nova Scotia Cancer Centre
Actively Recruiting
PhaseN/A
SponsorNova Scotia Cancer Centre
Started2023-01-18
Est. completion2024-11-21
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05483712
Summary
The hypothesis is that the daily use of brass mesh bolus achieves a comparable dose to every-other-day use of Superflab bolus (current standard of care) in chest wall post-mastectomy patients treated with rotational 6 MV photon delivery.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: Women undergoing rotational chest wall radiotherapy following mastectomy for breast cancer treatment who would utilize Superflab bolus on some, but not all, days of radiotherapy treatment. Exclusion Criteria: Patients who require daily bolus due to skin involvement or other high-risk features requiring a high skin dose will not be included.
Conditions2
Breast CancerCancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNova Scotia Cancer Centre
Started2023-01-18
Est. completion2024-11-21
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05483712